Perlecan Pharma Development
-
Hyderabad, Dec 26 (UNI) An anti-diabetic agent that works through new pathways, discovered by Dr Reddy's Laboratories and taken up for development by Perlecan Pharma, is undergoing Phase I clinical trials in the Netherlands.<br/><br/> The agent, DRL 16536, works by activating ...